| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | See Remarks
2 companies
Sinha Vikas is a Chief Financial Officer at SRRK, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 41 sales. Those positions are worth an estimated $31.2M at current prices.
Our model assigns Sinha Vikas a strong insider score of 83/100, based on 40 past trades. Over a 12-month horizon, 97.4% of those trades were profitable, with an average 12-month return of +60.5%.
Sinha Vikas's largest disclosed position is in SRRK as Chief Financial Officer, worth about $30.7M. The recent filings there lean toward selling, a net 27,165 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 4, 2024 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 961 | $0.64 | $614.08 | - | +14.3% | -32.4% | |
| Nov 17, 2023 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell10b5-1 | 2,490 | $1.63 | $4,061.44 | -0.2% | -57.7% | -65.1% | |
| Oct 20, 2023 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell10b5-1 | 2,707 | $1.56 | $4,219.54 | -0.2% | -54.3% | -48.8% | |
| Oct 3, 2023 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell10b5-1 | 755 | $1.98 | $1,492.11 | - | -66.4% | -59.8% | |
| Aug 17, 2023 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell10b5-1 | 10,516 | $2.50 | $26,242.68 | -0.9% | -32.0% | -69.9% | |
| Jul 20, 2023 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell10b5-1 | 2,635 | $3.44 | $9,076.89 | -0.2% | -51.4% | -77.5% | |
| Jul 5, 2023 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell10b5-1 | 2,983 | $3.05 | $9,083.53 | -0.3% | -35.7% | -78.1% | |
| Apr 20, 2023 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell10b5-1 | 2,683 | $3.66 | $9,828.47 | -0.2% | -10.1% | -80.2% | |
| Jan 20, 2023 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 6,537 | $5.09 | $33,287.18 | -0.6% | -28.0% | -87.0% | |
| Oct 19, 2022 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 1,449 | $9.36 | $13,563.65 | -0.1% | -40.8% | -83.6% |